Older Adults' Health

Topic Spotlight


The median life expectancy for the U.S. population is 78.6. (Administration for Community Living)


Medicare spent about $737 billion on health care for older individuals and people with disabilities in 2018. (Centers for Medicare & Medicaid Services)


PCORI supports 46 comparative clinical effectiveness research studies that aim to help older adults and their caregivers make better-informed decisions about their healthcare options. (As of February 2022)

2023 PCORI Annual Meeting Breakout Session Spotlight

Addressing the Needs of Older Adults: Highlights from PCORI's Funding Initiatives

Read more about this session

Study Results that Support Better-Informed Decisions

Study Finds Two Types of Anesthesia Safe, Effective for Hip Fracture Surgery

Every year, many of the 250,000 people who have surgery for hip fracture in the United States receive general anesthesia, but the use of regional anesthesia injected into the spine is rapidly increasing. A PCORI-funded randomized trial led by researchers at the University of Pennsylvania found that the two approaches are equally safe and effective.

Published in the New England Journal of Medicine, the study of 1,600 patients 50 and older at 46 hospitals across the United States and Canada found rates of survival, ability to walk, and post-operative delirium were similar for patients who had either anesthesia. The results could facilitate decision making about which option best fits a patient’s preferences.

Spotlights on Ongoing Studies and Projects

Improving Outcomes after Hip Fractures among Older Adults

Hip fractures send more than 300,000 older adults to hospitals each year, and the vast majority of patients must undergo surgery that requires anesthesia. Previous research suggests that spinal anesthesia may help patients get better faster and with less pain than general anesthesia.

This PCORI-funded study is comparing short- and long-term patient outcomes of general versus localized anesthesia for hip fracture surgery.

PREVENTABLE, New NIH Study Targeting Older Adults, Will Leverage PCORnet Data Resource

A $90 million National Institutes of Health-funded study known as "PREVENTABLE," which will be assessing statins' abilities to prevent dementia and other disabilities in older adults, will take advantage of PCORnet®, the National Patient-Centered Clinical Research Network.

This exciting study is the strongest demonstration yet that PCORnet has evolved into a valuable national resource that will help research get done faster and more efficiently. Find out more about the study.